2024
Racial Disparities in Telemedicine Uptake during the COVID-19 Pandemic among Patients with Hematologic Malignancies in the United States
Neparidze N, W. Lau K, Wang X, Huntington S, Jamy O, S. Calip G, Shah H, M. Stephens D, Miksad R, Parikh R, Takvorian S, Goyal G, Seymour E. Racial Disparities in Telemedicine Uptake during the COVID-19 Pandemic among Patients with Hematologic Malignancies in the United States. Medical Research Archives 2024, 12 DOI: 10.18103/mra.v12i2.5164.Peer-Reviewed Original ResearchAcute myelogenous leukemiaMantle cell lymphomaChronic lymphocytic leukemiaDiffuse large B-cell lymphomaFollicular lymphomaMultiple myelomaWhite patientsBlack patientsCell lymphomaHematologic malignanciesLymphocytic leukemiaTreatment categoriesElectronic health record (EHR)-derived de-identified databaseDiagnosis of acute myelogenous leukemiaLarge B-cell lymphomaTelemedicine uptakeActive patientsLines of therapyB-cell lymphomaMonthly visit ratesMyeloma patientsVisit ratesAnalyzed patientsMyelogenous leukemiaLymphoma
2014
Malignancies associated with epstein-barr virus: pathobiology, clinical features, and evolving treatments.
Neparidze N, Lacy J. Malignancies associated with epstein-barr virus: pathobiology, clinical features, and evolving treatments. Clinical Advances In Hematology And Oncology 2014, 12: 358-71. PMID: 25003566.Peer-Reviewed Original ResearchConceptsEpstein-Barr virusClinical featuresEBV-specific T-cell therapyInhibition of EBVTreatment of EBVT-cell lymphomaT-cell therapyNew treatment strategiesEBV vaccineImmune dysregulationHodgkin's lymphomaNasopharyngeal cancerTreatment strategiesGastric cancerTherapeutic approachesBurkitt's lymphomaEBV oncogenesisAntiviral drugsLymphoid neoplasmsViral infectionLymphomaImmunogenic propertiesLytic viral infectionPathobiologyMalignancy